<- Go Home
Specialty Laboratories, Inc.
Specialty Laboratories, Inc., doing business as Quest Diagnostics Nichols Institute of Valencia, Inc., operates a clinical reference laboratory. It engages in the research and development of new assays, as well as refinement of existing diagnostic tests. The company’s assays support testing in a range of clinical areas, including allergy and immunology, cardiology, coagulation, dermatopathology, endocrinology, gastroenterology, genetics, hepatology, infectious disease, microbiology, nephrology, neurology, oncology, pathology, pediatrics, rheumatology, toxicology, urology, and women's health. It serves hospitals and commercial labs in the United States. Specialty Laboratories, Inc. was formerly known as Clinical Immunology Laboratories, Inc. and changed its name to Specialty Laboratories, Inc. in January 1985. The company was incorporated in 1975 and is based in Valencia, California. Specialty Laboratories, Inc. operates as a subsidiary of AmeriPath, Inc.
Market Cap
$316.6M
Volume
37.0K
Cash and Equivalents
$17.0M
EBITDA
$1.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$48.5M
Profit Margin
32.34%
52 Week High
$15.10
52 Week Low
$6.55
Dividend
N/A
Price / Book Value
3.05
Price / Earnings
-15.26
Price / Tangible Book Value
3.26
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$5.2M
Return on Equity
18.11%
Return on Assets
-2.58
Cash and Short Term Investments
$17.0M
Debt
N/A
Equity
$103.7M
Revenue
$150.0M
Unlevered FCF
-$5.2M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium